Page last updated: 2024-09-05

bifeprunox and gr 218231

bifeprunox has been researched along with gr 218231 in 1 studies

Compound Research Comparison

Studies (bifeprunox)	Trials (bifeprunox)	Recent Studies (post-2010) (bifeprunox)	Studies (gr 218231)	Trials (gr 218231)	Recent Studies (post-2010) (gr 218231)
30	1	12	6	0	0

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnt, J; Bétry, C; Etievant, A; Haddjeri, N	1

Other Studies

1 other study(ies) available for bifeprunox and gr 218231

Article	Year
Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Neuroscience letters, 2009, Aug-21, Volume: 460, Issue:1 Topics: Action Potentials; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Indoles; Male; Neurons; Piperazines; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulfones; Tetrahydronaphthalenes; Ventral Tegmental Area	2009

Article

Year

Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.

Neuroscience letters, 2009, Aug-21, Volume: 460, Issue:1

Topics: Action Potentials; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Indoles; Male; Neurons; Piperazines; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulfones; Tetrahydronaphthalenes; Ventral Tegmental Area

2009